<DOC>
	<DOC>NCT00762463</DOC>
	<brief_summary>This is a local, multicenter, randomized, active comparator, double-blind, parallel group study with extension will be conducted to evaluate the efficacy and safety of celecoxib versus diclofenac SR in the treatment of Chinese patients with Ankylosing Spondylitis (AS).</brief_summary>
	<brief_title>Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Meet the 1984 Modified New York Criteria for Classification of Ankylosing Spondylitis With axial involvement Without peripheral joint involvement (synovitis) at the time of study entry, (excluding involvement of the hips, knees and shoulders) Need for daily treatment with NSAIDs during the previous 30 days before study entry Known inflammatory enteropathy (eg, ulcerative colitis, Crohn's disease, etc) Presence of extraarticular manifestations (eg, uveitis, endocarditis, etc.) Known vertebral compression Need for a corset during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>